Psoriasis

Phase 1b Double-blind, Placebo-controlled, Multi-Center Study of Fluphenazine HCL Monotherapy in Psoriasis

• Ongoing multicenter study in the United States.
• Primary objective: evaluate the safety, tolerability, and efficacy of fluphenazine when administered intralesionally.